GlassScriptPhysician profile
Abhinav Humar
NPI 1487687588
$56,648.45
in general payments reported to CMS, 2019-2025
9 companies · $76.76 in 2025
The $76.76 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2021: $8,908 · 2022: $46K · 2023: $200 · 2024: $931 · 2025: $76.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,060 · Food and Beverage: $103 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,060.00 |
| Food and Beverage | $102.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $52,345.71 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,860.00 | 2021 | |
| Zoll Medical Corporation | $1,150.00 | 2022-2024 | Defibrillator |
| Saol Therapeutics INC. | $439.83 | 2019 | |
| Medtronic, INC. | $400.00 | 2021-2025 | Surgipro Ll, Endo Clip III, Ta |
| Melinta Therapeutics, LLC | $305.00 | 2024 | |
| Ethicon US, LLC | $56.15 | 2024 | Monocryl, Stratafix |
| Paragonix Technologies, INC. | $46.76 | 2025 | Liverguard |
| Becton, Dickinson and Company | $45.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Humar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.